Arizona Liver Health

Arizona Liver Health, along with our Chief Medical Officer, Dr. Naim Alkhouri, MD, FAASLD, is excited to participate in the Paris MASH Meeting Takeaways webinar, where we’ll share key updates from the Paris MASH Meeting. Join us, along with our distinguished colleagues Michael Betel, Attila Timar-Pereguin, Jörn M. Schattenberg, and Mark Swain, as we explore the latest innovations and practical applications in MASH research and patient care.    Don’t miss this chance to stay at the cutting edge of MASH clinical trials. Register now: https://ow.ly/GIL450T4pCv #ALH #ArizonaLiverHealth #WorldwideClinicalTrials #MASH #Research #Care Anita Kohli Richard Manch Ann Moore BrightTALK Worldwide Clinical Trials Tessa Janovsky Angie Coste Esteban Rafael Lugo Morales Michelle Jones Nick Engelke Kelly Black

We have exciting news to share! The U.S. Food and Drug Administration has approved a new medication for liver disease treatment called Livdelzi® (seladelpar). This once-daily pill is a game-changer for patients with primary biliary cholangitis (PBC), offering significant benefits such as reduced alkaline phosphatase (ALP) levels and relief from PBC-related itching—a common symptom affecting more than half of those with PBC. LIVDELZI is now available as a prescription medication for treating PBC in adults. It can be used in combination with UDCA (ursodeoxycholic acid) for patients who haven’t responded well to UDCA alone or as a standalone treatment for those who cannot tolerate UDCA. PBC is a chronic condition that causes inflammation and damage to the small bile ducts in the liver, primarily impacting women aged 35 to 60. This new treatment brings hope and a vital new option for managing this disease. "We are thrilled to be able to prescribe LIVDELZI to better support our patients suffering from PBC," says Chief Medical Marketing Officer, Dr. Naim Alkhouri. For HCP information click here: https://lnkd.in/giwQ5Zq5 #PBC #Livdelzi #ALH Naim Alkhouri, MD, FAASLD Anita Kohli Richard Manch Ann Moore Yessica Sachdeva Tessa Janovsky Esteban Rafael Lugo Morales Reichard R. Angie Coste Mazen Noureddin, MD, MHSc Fatty Liver Alliance Gilead Sciences Michelle Jones Kelly Black Nick Engelke Anne Payne Desirae Trotter John Raslavsky

Naim Alkhouri, MD, FAASLD explains the value of AGILE 3+ and AGILE 4, reviewing key findings from a recent study applying the scores to NHANES data to estimate MASLD fibrosis and cirrhosis. Anita Kohli Tessa Janovsky HCPLive Kelly Black Michelle Jones Angie Coste Jesus Topete Esteban Lugo Morales

We're #hiring a new Clinic Advanced Practice Provider (APP) in Peoria, Arizona. Apply today or share this post with your network.

Celebrate the Grand Opening of ACT Medical Park - our new state-of-the-art, 28,000 sq. ft. medical facility! We are excited to announce the grand opening of our innovative ACT Medical Park in Chandler, Arizona! This event marks the introduction to our ACT Phase 1 Unit and ACT Imaging, advancing healthcare and clinical research. We invite you to join us to explore this groundbreaking facility and see firsthand the future of clinical trials with Arizona Liver Health / Arizona Clinical Trials. The ACT Phase 1 Unit features 24 private rooms, a USP 800-compliant research pharmacy, a sophisticated research laboratory, and a team of experienced professionals. Our extensive patient database is equipped to support a diverse range of studies, including hepatic and renal impairment Phase 1 trials, with the capability to accommodate subjects requiring hemodialysis. ACT Imaging is outfitted with cutting-edge research technology, including 3T MRI, MRI-PDFF, MRE, PET/CT, X-ray, DEXA, OPTOS, and Ultrasound. As one of only five MRI facilities in Arizona offering specialized disease diagnostics and monitoring capabilities, we are eager to drive advancements in research and patient care. We welcome our local referring HCP's, research colleagues, pharmaceutical and CRO partners to join us on September 19th for the Grand Opening Ribbon Cutting Ceremony! Scan the QR Code below or email Desirae Trotter: dtrotter@azliver.com Location: ACT Medical Park, 910 E. Pecos Rd., Chandler, AZ 85225 : featuring Arizona Liver Health, Arizona Clinical Trials, VEN Centers, ACT Imaging, ALH|VEN Pharmacy, and the Arizona State Urological Institute. We look forward to showcasing our research innovations and discussing collaborative opportunities with you! #AMP #ACTMedicalPark #ALH #ACT #Clinicalresearch Anita Kohli Naim Alkhouri, MD, FAASLD Ann Moore Richard Manch Yessica Sachdeva Angie Coste Michelle Jones Kelly Black Nick Engelke Desirae Trotter Anne Payne Tessa Janovsky Jesus Topete Esteban Lugo Morales

Don't forget, the exclusive webinar hosted by Summit Clinical Research is today! Join us with our esteemed Chief Medical Officer, Dr. Alkhouri, as he leads a session on "Identifying Patients for MASH Cirrhosis Trials." This event is in collaboration with Arizona Liver Health. Don't miss out on valuable insights from a leading expert in the field. Secure your spot here: https://lnkd.in/g9ujKJVu, or scan the QR code. #ALH #ArizonaLiverHealth #Webinar #SummitClinicalResearch #Dontmissout Naim Alkhouri, MD, FAASLD Anita Kohli Richard Manch Tessa Janovsky Ann Moore Rashmee Patil Angie Coste Yessica Sachdeva Esteban Lugo Morales Reichard R. Michelle Jones Nick Engelke Kelly Black Anne Payne Pinnacle Clinical Research

We're #hiring a new Research Manager in Chandler, Arizona. Apply today or share this post with your network.

We're #hiring a new Research Manager in Tucson, Arizona. Apply today or share this post with your network.

We're #hiring a new Instructional Designer in Chandler, Arizona. Apply today or share this post with your network.

We're #hiring a new Research Advanced Practice Provider (APP) in Chandler, Arizona. Apply today or share this post with your network.